安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- KRAS - Wikipedia
KRAS (Kirsten rat sarcoma virus oncogene homologue) is a gene that provides instructions for making a protein called K-Ras, a part of the RAS MAPK pathway The protein relays signals from outside the cell to the cell's nucleus
- Targeting KRAS mutations: orchestrating cancer evolution and . . .
In this review, we provide a brief overview of KRAS mutations in cancers and tumorigenesis, specifically focusing on currently approved therapies for targeting KRAS, ongoing advances,
- What Is KRAS and Why Is It So Hard to Target in Cancer?
Current KRAS G12C inhibitors in non-small cell lung cancer show response rates of about 30% to 40% and a median progression-free survival of around six months How should patients understand what these numbers mean in practical terms today? In practical terms, these numbers mean that a meaningful benefit is seen in a portion of patients
- First-in-Class Investigational Drug KRAS G12D Degrader Shows Promise in . . .
A new drug called setidegrasib targets a gene mutation called KRAS G12D, which causes cancer cells to grow out of control This mutation is responsible for about 40% of pancreatic cancers and 5% of lung cancers, making it an important target for treatment
- KRAS-targeted therapies in cancer: novel approaches and overcoming . . .
In normal cells, KRAS activation is transient and tightly regulated by upstream growth factors, receptor tyrosine kinases (RTKs) and intrinsic negative feedback mechanisms
- KRAS Inhibitors (2026): The Complete Guide to Targeted Therapy . . .
Today, KRAS is no longer a scientific dead end—it is one of the most actively targeted oncogenic drivers in modern precision medicine Multiple generations of KRAS inhibitors now exist, and treatment strategies are evolving from single-mutation targeting toward pan-RAS pathway control and combination therapy systems
- What’s new in KRAS mutation research? | UT MD Anderson
The most frequently mutated of these oncogenic driver genes, called KRAS, is associated with some of the most fatal cancer types: lung, pancreatic and colorectal cancers
- KRAS Oncoprotein Signaling in Cancer - The New England Journal of Medicine
Recent studies provide new insights into signaling by mutant KRAS, inhibitors of which have provided modest benefits for patients
|
|
|